Glucocorticoids [e.g., corticosterone and dexamethasone (Dex)], when administered systemically, greatly increase water drinking elicited by angiotensin and sodium ingestion in response to mineralocorticoids [e.g., aldosterone and deoxycorticosterone acetate (DOCA)], possibly by acting in the brain. In addition, glucocorticoids exert powerful renal actions that could influence water and sodium ingestion by promoting their excretion. To test this, we determined water and sodium intakes, excretions, and balances during injections of Dex and DOCA and their coadministration (DOCAϩDex) at doses commonly employed to stimulate ingestion of water and sodium. In animals having only water to drink, Dex treatment greatly increased water and sodium excretion without affecting water intake, thereby producing negative water and sodium balances. Similar results were observed when Dex was administered together with DOCA. In animals having water and saline solution (0.3 M NaCl) to drink, Dex treatment increased water and sodium excretion, had minimal effects on water and sodium intakes, and was associated with negative water and sodium balances. DOCA treatment progressively increased sodium ingestion, and both water and sodium intakes exceeded their urinary excretion, resulting in positive water and sodium balances. The combination of DOCAϩDex stimulated rapid, large increases in sodium ingestion and positive sodium balances. However, water excretion outpaced total fluid intake, resulting in large, negative water balances. Plasma volume increased during DOCA treatment and did not change during treatment with Dex or DOCAϩDex. We conclude that increased urinary excretion, especially of water, during glucocorticoid treatment may explain the increased ingestion of water and sodium that occurs during coadministration with mineralocorticoids. thirst; urine volume; dexamethasone; deoxycorticosterone acetate; food intake SYSTEMICALLY ADMINISTERED mineralocorticoids, such as aldosterone and deoxycorticosterone acetate (DOCA), stimulate vigorous sodium ingestion by activating mineralocorticoid receptors in the brain. Glucocorticoids, such as corticosterone, greatly increase this salt appetite response when coadministered with mineralocorticoids (2,17,33,35). Systemically administered glucocorticoids also increase water drinking in response to peripheral and central administration of ANG II (9, 27). The potentiation of salt appetite and thirst by glucocorticoids has been postulated to arise from glucocorticoid actions within the brain, affecting either mineralocorticoid (17, 35) or ANG II (3,6,8,22) receptors. For example, high levels of glucocorticoids are proposed to increase type I mineralocorticoid receptors and thus mineralocorticoid binding in the brain (17,35). Additionally, glucocorticoids may increase the number of ANG II receptors in the brain (22) and thereby augment the central actions of ANG II (which, in turn, may interact with mineralocorticoid receptors).Glucocorticoids also have systemic effects that could facilitate ingest...